Riskpilot← Back to searchSign inGet full accessNovonesis Plant Biosolutions A/S
A/SActiveCVR 30919246Biologiens Vej 2Leasing of intellectual property and similar products, except copyrighted works · NACE 7740Est. 2007— employees
Revenue 2024
DKK 116,7M
+4% vs 2023
EBITDA margin
393.7%
+9% vs 2023
Equity ratio
77.6%
Financial strength
Net profit 2024
DKK 403,9M
+31% vs 2023
| Revenue | DKK 116,7M | +4% |
| EBITDA | DKK 459,5M | +9% |
| Net profit | DKK 403,9M | +31% |
| Total assets | DKK 944,3M | -3% |
| Equity | DKK 733,2M | +1% |
| Employees | — | — |
Legal name
Novonesis Plant Biosolutions A/S
CVR number
30919246
Legal form
Aktieselskab
NACE code
7740 · Leasing of intellectual property and similar products, except copyrighted works
Founded
22. oktober 2007
Share capital
DKK 600.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem eller af en direktør.
Company purpose
Selskabets formål er drift af og investering i forskning, udvikling, produktion og handel med biologiske løsninger, herunder bioteknologiske produkter og processer samt at drive virksomhed, der efter bestyrelsens nærmere bestemmelse står i forbindelse hermed. Selskabet tilstræber at drive sin virksomhed på bæredygtig og ansvarlig vis, herunder i økonomisk, miljømæssig og social henseende.
Address
Biologiens Vej 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 149.425 | 133.335 | 148.562.040 | 112.487 | 116.711 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 201.916 | 232.609 | 255.018.240 | 422.227 | 459.478 |
| Depreciation & amort. | -174.705 | -110.660 | -109.562 | -22.072 | -2.373 |
| EBIT | 27.211 | 121.949 | 254.908.678 | 400.155 | 457.105 |
| Net financials | -21.836 | 25.376 | 78.062 | -7.656 | 21.306 |
| Profit before tax | 5.375 | 147.325 | 332.971 | 392.499 | 478.411 |
| Tax | 15.335 | 28.150 | -60.152 | 83.487 | 74.484 |
| Net profit | -9.960 | 119.175 | 272.818.768 | 309.012 | 403.927 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 798.882 | 823.091 | 1.022.644.401 | 972.524 | 944.319 |
| Equity | 593.266 | 637.441 | 820.259.280 | 729.271 | 733.198 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 148.786 | 153.055 | 194.332 | 197.233 | 202.879 |
| Total debt | 148.786 | 153.055 | 194.332 | 197.233 | 202.879 |
EBITDA margin
393.7%
This company
15.8%
Market median
+2392% vs market
20202024
Equity ratio
77.6%
This company
38.2%
Market median
+103% vs market
20202024
Return on equity
55.1%
This company
18.4%
Market median
+199% vs market
20202024
Net profit margin
346.1%
This company
8.1%
Market median
+4173% vs market
20202024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20202024
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LK Management | Management | 2024 |
| Former (3) | ||
TV Chief Executive Officer | Chief Executive Officer | 2007 – 2021 |
LG Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
RC Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2010 | |
| Former (3) | ||
| Board of Directors | 2007 – 2017 | |
| Chairman | 2007 – 2010 | |
| Board of Directors | 2017 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NOVO NORDISK FONDEN
Novonesis Plant Biosolutions A/S Board members of Novonesis Plant Biosolutions A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Videbæk | Chief Executive Officer | 0 companies |
| Lisbet Kragelund | Management | 0 companies |
| Lars Green | Chief Executive Officer | 0 companies |
| Randi Camilla Kinch Jensen | Chief Executive Officer | 0 companies |
| Rainer Chapour Lehmann | Board of Directors | 0 companies |
| Benny Dalgaard Loft | Board of Directors | 0 companies |
| Kristian Merser | Chairman | 0 companies |
| Mikkel Viltoft | Chairman | 0 companies |
| Tina Sejersgård Fanø | Board of Directors | 0 companies |